Addus (ADUS) Insider Sale: Director Sells 1,571 Shares at $114.93

Rhea-AI Filing Summary

Form 4: Veronica Hill-Milbourne, a director of Addus HomeCare Corp. (ADUS), sold 1,571 shares of common stock on 08/19/2025 at a reported price of $114.93 per share, reducing her direct beneficial ownership to 5,067 shares. The filing was signed by an attorney-in-fact on 08/21/2025. This report discloses an insider sale and the remaining direct ownership stake held by the reporting person.

Insights

Securities Analyst

TL;DR: Routine director sale; size modest relative to typical outstanding shares, no new compensation or option exercise disclosed.

The Form 4 shows a straightforward open-market sale of 1,571 shares at $114.93, leaving 5,067 shares held directly. There are no derivative transactions or new grants reported. For market impact, the disclosed sale is a routine insider liquidity event and, by itself, does not indicate a change in corporate strategy or firm fundamentals.

Corporate Governance Expert

TL;DR: Insider sale by a director appears ordinary and fully reported; documentation includes attorney-in-fact signature.

The filing accurately identifies the reporting person as a director and uses the correct transaction code (S for sale). The signature by an attorney-in-fact on 08/21/2025 is provided, satisfying Form 4 execution requirements. No indications of unusual governance events, such as accelerated sales tied to departure or related-party transactions, are present in the document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hill-Milbourne Veronica

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		S		1,571	D	$114.93	5,067	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian Poff, Attorney-In-Fact for Veronica Hill-Milbourne	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ADUS director Veronica Hill-Milbourne report on Form 4?

The director reported a sale of 1,571 shares of Addus HomeCare (ADUS) common stock on 08/19/2025 at $114.93 per share, leaving 5,067 shares beneficially owned.

How many shares does Veronica Hill-Milbourne own after the reported transaction?

After the sale, she directly beneficially owns 5,067 shares of ADUS common stock as reported on the Form 4.

What type of transaction code is used in the filing?

The filing uses transaction code S, indicating a sale of securities.

When was the Form 4 signed and by whom?

The Form 4 was signed by Brian Poff, Attorney-In-Fact for Veronica Hill-Milbourne on 08/21/2025.

Does the Form 4 report any option exercises or derivative transactions for ADUS?

No. Table II for derivative securities is blank and the filing shows only a non-derivative common stock sale.